Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era.

Gabriella GiancaneValentina MuratoreValentina MarzettiNeus QuilisBelen Serrano BenaventeFrancesca BagnascoAlessandra AlongiAdele CivinoLorenzo QuartulliAlessandro ConsolaroAngelo Ravelli

Published in: Arthritis research & therapy (2019)

Our study provides evidence of the remarkable outcome improvement obtained with the recent therapeutic advance in JIA.

Keyphrases

juvenile idiopathic arthritis
disease activity
rheumatoid arthritis
systemic lupus erythematosus
rheumatoid arthritis patients
ankylosing spondylitis
oxidative stress
high dose
low dose